Discovery of VU0467485/AZ13713945: An M4 PAM Evaluated as a Preclinical Candidate for the Treatment of Schizophrenia

Overview of attention for article published in ACS Medicinal Chemistry Letters, December 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Good Attention Score compared to outputs of the same age and source (69th percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 5,158 followers.

VU0467485/AZ13713945はM4PAM https://t.co/ctlRX7qXxp further advancement of 6c was halted (pending pharmaceutical sciences work) とあるので、進捗が止まってそう

A new M4 PAM preclinical candidate to treat schizophrenia from @VICB_Vanderbilt investigators CW Lindsley. https://t.co/qCcjFU4CrR

A new M4 PAM preclinical candidate to treat schizophrenia from @tweetbasicsci investigators Lindsley, Conn, & Jones https://t.co/F9lsElpK8I

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.